<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Stroke</journal-id><journal-id journal-id-type="iso-abbrev">Int J Stroke</journal-id><journal-id journal-id-type="publisher-id">WSO</journal-id><journal-id journal-id-type="hwp">spwso</journal-id><journal-title-group><journal-title>International Journal of Stroke</journal-title></journal-title-group><issn pub-type="ppub">1747-4930</issn><issn pub-type="epub">1747-4949</issn><publisher><publisher-name>SAGE Publications</publisher-name><publisher-loc>Sage UK: London, England</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39629687</article-id><article-id pub-id-type="pmc">PMC11786522</article-id>
<article-id pub-id-type="doi">10.1177/17474930241307876</article-id><article-id pub-id-type="publisher-id">10.1177_17474930241307876</article-id><article-categories><subj-group subj-group-type="heading"><subject>WSO Factsheets</subject></subj-group></article-categories><title-group><article-title>World Stroke Organization (WSO): Global intracerebral hemorrhage factsheet 2025</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-4462-3846</contrib-id><name><surname>Parry-Jones</surname><given-names>Adrian R</given-names></name><xref rid="aff1-17474930241307876" ref-type="aff">1</xref><xref rid="aff2-17474930241307876" ref-type="aff">2</xref><xref rid="corresp1-17474930241307876" ref-type="corresp"/></contrib><contrib contrib-type="author"><name><surname>Krishnamurthi</surname><given-names>Rita</given-names></name><xref rid="aff3-17474930241307876" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Ziai</surname><given-names>Wendy C</given-names></name><xref rid="aff4-17474930241307876" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-2802-1626</contrib-id><name><surname>Shoamanesh</surname><given-names>Ashkan</given-names></name><xref rid="aff5-17474930241307876" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-4557-7386</contrib-id><name><surname>Wu</surname><given-names>Simiao</given-names></name><xref rid="aff6-17474930241307876" ref-type="aff">6</xref><xref rid="aff7-17474930241307876" ref-type="aff">7</xref></contrib><contrib contrib-type="author"><name><surname>Martins</surname><given-names>Sheila O</given-names></name><xref rid="aff8-17474930241307876" ref-type="aff">8</xref><xref rid="aff9-17474930241307876" ref-type="aff">9</xref></contrib><contrib contrib-type="author"><name><surname>Anderson</surname><given-names>Craig S</given-names></name><xref rid="aff10-17474930241307876" ref-type="aff">10</xref><xref rid="aff11-17474930241307876" ref-type="aff">11</xref></contrib></contrib-group><aff id="aff1-17474930241307876"><label>1</label>Geoffrey Jefferson Brain Research Centre, Manchester Academic Health Science Centre, Northern Care Alliance and University of Manchester, Manchester, UK</aff><aff id="aff2-17474930241307876"><label>2</label>Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK</aff><aff id="aff3-17474930241307876"><label>3</label>National Institute of Stroke and Applied Neurosciences, School of Clinical Sciences, Auckland University of Technology, Auckland, New Zealand</aff><aff id="aff4-17474930241307876"><label>4</label>Departments of Neurology, Neurosurgery and Anaesthesiology/Critical Care Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA</aff><aff id="aff5-17474930241307876"><label>5</label>Department of Medicine (Neurology), McMaster University and Population Health Research Institute, Hamilton, ON, Canada</aff><aff id="aff6-17474930241307876"><label>6</label>Department of Neurology, West China Hospital, Sichuan University, Chengdu, P.R. China</aff><aff id="aff7-17474930241307876"><label>7</label>Centre for Cerebrovascular Diseases, West China Hospital, Sichuan University, Chengdu, P.R. China</aff><aff id="aff8-17474930241307876"><label>8</label>Neurology Service, Hospital de Cl&#x000ed;nicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil</aff><aff id="aff9-17474930241307876"><label>9</label>Neurology Service, Hospital Moinhos de Vento, Porto Alegre, Brazil</aff><aff id="aff10-17474930241307876"><label>10</label>Institute of Science and Technology for Brain-Inspired Intelligence, Fudan University, Shanghai, China</aff><aff id="aff11-17474930241307876"><label>11</label>The George Institute for Global Health, Sydney, NSW, Australia</aff><author-notes><corresp id="corresp1-17474930241307876">Adrian R Parry-Jones, Geoffrey Jefferson Brain Research Centre, Manchester Academic Health Science Centre, Northern Care Alliance and University of Manchester, Clinical Sciences Building, Salford Royal Hospital, Stott Lane, Salford, Manchester M6 8HD, UK. Email: <email>adrian.parry-jones@manchester.ac.uk</email></corresp></author-notes><pub-date pub-type="epub"><day>6</day><month>1</month><year>2025</year></pub-date><pub-date pub-type="ppub"><month>2</month><year>2025</year></pub-date><volume>20</volume><issue>2</issue><fpage>145</fpage><lpage>150</lpage><history><date date-type="received"><day>28</day><month>10</month><year>2024</year></date><date date-type="accepted"><day>27</day><month>11</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; 2025 World Stroke Organization</copyright-statement><copyright-year>2025</copyright-year><copyright-holder content-type="society">World Stroke Organization</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the Creative Commons Attribution 4.0 License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (<ext-link ext-link-type="uri" xlink:href="https://us.sagepub.com/en-us/nam/open-access-at-sage">https://us.sagepub.com/en-us/nam/open-access-at-sage</ext-link>).</license-p></license></permissions><abstract><sec id="section1-17474930241307876"><title>Background:</title><p>Intracerebral hemorrhage (ICH) is stroke caused by non-traumatic bleeding into the brain.</p></sec><sec id="section2-17474930241307876"><title>Aim:</title><p>This factsheet provides summary statistics for ICH from the 2021 Global of Burden of Diseases Study.</p></sec><sec id="section3-17474930241307876"><title>Methods:</title><p>Data were downloaded from the GBD results platform using &#x0201c;intracerebral hemorrhage&#x0201d; as a Level 4 cause of death or injury, extracting key metrics (number, percent, rate) for measures (incidence, disabilty adjusted life years [DALYs], deaths) described in this factsheet.</p></sec><sec id="section4-17474930241307876"><title>Results:</title><p>Globally, stroke was the third leading cause of death in 2021, and ICH accounted for 28.8% of incident strokes. There were estimated to be 7,252,678 deaths due to stroke in 2021 of which ICH accounted for 3,308,367 (45.6%). When considering the burden of ICH in terms of DALYs, ICH accounts for nearly half of the burden of stroke at 49.5%, compared to 43.8% caused by ischemic stroke. ICH must therefore be considered on an equal footing with ischemic stroke, so that efforts can be made to reduce its burden through public health, research, and healthcare provision. Although the overall age-standardized incidence of ICH has been decreasing since 1990, the rate of reduction has been much slower in regions with lower socio-demographic index (SDI). Most of the burden of ICH lies in areas with lower SDI, with 94.2% of DALYs lost to ICH outside areas of high SDI. Geographically, the majority of DALYs due to ICH occur in Southeast Asia, East Asia, and Oceania, with 53.3% of global DALYs lost in these regions alone. The risk factors for ICH are dominated by high systolic blood pressure, which accounts for at least 50% of the burden of ICH, regardless of SDI. Areas with middle or high-middle SDI have a greater proportion of the burden of ICH accounted for by ambient particulate pollution, smoking, and diets high in sodium, whereas household air pollution from solid fuels accounts for much more of the risk of ICH in low SDI regions.</p></sec><sec id="section5-17474930241307876"><title>Conclusion:</title><p>This World Stroke Organization (WSO) Global ICH Fact Sheet 2025 provides the most updated information on ICH that can be used to support communication with all internal and external stakeholders, inform healthcare policy, and raise public awareness. All statistics have been reviewed and approved for use by the WSO Executive Committee.</p></sec></abstract><kwd-group><kwd>Intracerebral hemorrhage</kwd><kwd>epidemiology</kwd><kwd>risk factors</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>typesetter</meta-name><meta-value>ts1</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="section6-17474930241307876"><title>Overview</title><p>Stroke was the third leading cause of death in the 2021 Global Burden of Disease (GBD) study,<sup>
<xref rid="bibr1-17474930241307876" ref-type="bibr">1</xref>
</sup> having been displaced from the second leading cause of death in 2019 by COVID-19.<sup>
<xref rid="bibr2-17474930241307876" ref-type="bibr">2</xref>
</sup> Intracerebral hemorrhage (ICH) is stroke caused by non-traumatic hemorrhage into the brain.<sup>
<xref rid="bibr3-17474930241307876" ref-type="bibr">3</xref>
</sup> Together with ischemic stroke and subarachnoid hemorrhage, it is one of three major pathological types of stroke. The most recent 2021 Global Burden of Disease data show that globally stroke has an annual, age-standardized incidence of 141.55 (95% uncertainty interval [UI] 127.97 to 155.81) per 100,000 population. ICH has an incidence of 40.83 (95% UI 36.2 to 45.21) per 100,000, accounting for 28.8% of incident strokes. Ischemic stroke has over twice the incidence (92.39 [95% UI 79.84 to 105.82] per 100,000), accounting for 65.3% of incident strokes. However, when considering the overall burden of ICH in relation to ischemic stroke, ICH accounts for nearly as many deaths and more disability adjusted life years (DALYs). There were estimated to be 7,252,678 deaths in 2021 due to stroke of which ICH accounted for 3,308,367 (45.6%), compared to 3,591,499 (49.5%) for ischemic stroke. Stroke caused 160,457,220 DALYs, with ICH accounting for 49.6% of total DALYs due to stroke, and ischemic stroke less, at 43.8%. Death and disability after ICH can be reduced by consistent and effective delivery of guideline-based care, including blood pressure management, neurosurgery, and high-quality supportive care on dedicated stroke units and critical care units.<sup>
<xref rid="bibr4-17474930241307876" ref-type="bibr">4</xref>
</sup> Combining interventions in acute care bundles has shown benefit in both high- and low-middle income countries.<sup><xref rid="bibr5-17474930241307876" ref-type="bibr">5</xref>,<xref rid="bibr6-17474930241307876" ref-type="bibr">6</xref></sup></p><p>Annual GBD data from 1990 to 2021 shows that the age-standardized incidence of ICH is considerably lower in high socio-demographic index (SDI) countries but is decreasing across all SDI groups, although the trends are slower in low- and low-middle SDI countries (<xref rid="fig1-17474930241307876" ref-type="fig">Figure 1(a)</xref>). Absolute incidence shows a more complex pattern due to changing age distributions. Following a gradual reduction in absolute incidence for all SDI levels from approximately 2005 to 2014, a consistent increase in incidence across all SDI levels has occurred since, except for low SDI countries (<xref rid="fig1-17474930241307876" ref-type="fig">Figure 1(b)</xref>).</p><fig position="float" id="fig1-17474930241307876"><label>Figure 1.</label><caption><p>Age-standardized (a) and absolute (b) incidence of intracerebral hemorrhage, divided by socio-demographic index (SDI) from 1990 to 2021.</p></caption><graphic xlink:href="10.1177_17474930241307876-fig1" position="float"/></fig><p>Most of the burden of ICH occurs in areas with lower SDI, with 94.2% of DALYs lost to ICH occurring outside areas of high SDI. Geographically, the majority of DALYs are lost in Southeast Asia, East Asia, and Oceania, with 53.3% of global DALYs lost in this region alone (<xref rid="fig2-17474930241307876" ref-type="fig">Figure 2</xref>). ICH is increasingly common with age (<xref rid="table1-17474930241307876" ref-type="table">Table 1</xref>), with the highest incidence in those aged 70&#x02009;years or more. The incidence, prevalence, deaths, and DALYs are all slightly higher in men than women. The risk factors accounting for ICH are dominated by high systolic blood pressure (<xref rid="fig3-17474930241307876" ref-type="fig">Figure 3</xref>). It remains the leading risk factor for ICH regardless of SDI status, contributing to 51.8% of the ICH burden in low SDI areas compared to 58.7% of the ICH burden in high-middle SDI areas. There is considerably more variation in the importance of ambient particulate matter pollution by SDI, accounting for 20.3% of the burden in middle SDI and 20.2% in high-middle SDI areas versus 7.5% in low SDI and 11.5% in high SDI areas. A similar pattern is noted for smoking, with the greatest contribution in middle and high-middle SDI regions (17.5% and 19.9%, respectively), compared to low SDI regions (7.4%). Likewise, a diet high in sodium accounts for more risk in high-middle (15.5%) and middle (14.1%) SDI regions versus low SDI (4.7%) regions. These risks may thus represent an important focus for regions with middle or high-middle SDI, modifiable through public health interventions. For low SDI regions, household air pollution from solid fuels accounts for much more of the risk at 37.0%, compared to 0.04% in high SDI and 8.0% in middle SDI regions.</p><fig position="float" id="fig2-17474930241307876"><label>Figure 2.</label><caption><p>Percent of total DALYs lost to intracerebral hemorrhage by country in 2021.</p></caption><graphic xlink:href="10.1177_17474930241307876-fig2" position="float"/></fig><table-wrap position="float" id="table1-17474930241307876"><label>Table 1.</label><caption><p>GBD 2021 estimates for global incidence, prevalence, mortality, and disability-adjusted life years (DALYs) for intracerebral hemorrhage.</p></caption><alternatives><graphic xlink:href="10.1177_17474930241307876-table1" position="float"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Metric</th><th align="left" rowspan="1" colspan="1">Number</th><th align="left" rowspan="1" colspan="1">Crude rate per 100,000 per year (95% UI<sup>
<xref rid="table-fn1-17474930241307876" ref-type="table-fn">a</xref>
</sup>)</th><th align="left" rowspan="1" colspan="1">Age-adjusted rate per 100,000 per year (95% UI)</th><th align="left" rowspan="1" colspan="1">Approved statement for use in WSO materials</th></tr></thead><tbody><tr><td colspan="5" rowspan="1">Incidence</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Ages (all), sexes (both)</td><td rowspan="1" colspan="1">3,444,338</td><td rowspan="1" colspan="1">43.65 (38.69-48.31)</td><td rowspan="1" colspan="1">40.83 (36.2-45.21)</td><td rowspan="1" colspan="1">There are over 3.4 million new cases of intracerebral hemorrhage each year. Globally, 29% of all incident strokes are due to intracerebral hemorrhage</td></tr><tr><td rowspan="1" colspan="1">&#x02003;15-49&#x02009;years</td><td rowspan="1" colspan="1">613,694</td><td rowspan="1" colspan="1">15.54 (12.66-18.86)</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">Each year, 18% of all intracerebral hemorrhages occur in people aged between 15 and 49&#x02009;years</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x0003c;70&#x02009;years</td><td rowspan="1" colspan="1">1,943,503</td><td rowspan="1" colspan="1">26.27 (22.25-30.23)</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">Each year, 56% of all intracerebral hemorrhages occur in people under the age of 70&#x02009;years</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Men (all ages)</td><td rowspan="1" colspan="1">1,920,625</td><td rowspan="1" colspan="1">48.51 (42.78-53.92)</td><td rowspan="1" colspan="1">48.71 (43.07-54.27)</td><td rowspan="1" colspan="1">Each year, 56% of all intracerebral hemorrhages occur in men</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Women (all ages)</td><td rowspan="1" colspan="1">1,523,713</td><td rowspan="1" colspan="1">38.75 (33.88-43.04)</td><td rowspan="1" colspan="1">33.61 (29.47-37.22)</td><td rowspan="1" colspan="1">Each year, 44% of all intracerebral hemorrhages occur in women</td></tr><tr><td colspan="5" rowspan="1">Prevalence</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Ages (all), sexes (both)</td><td rowspan="1" colspan="1">16,603,836</td><td rowspan="1" colspan="1">210.41 (192.1-230.42)</td><td rowspan="1" colspan="1">194.51 (177.99-212.53)</td><td rowspan="1" colspan="1">Globally, there are over 16 million people currently living who have experienced an intracerebral hemorrhage</td></tr><tr><td rowspan="1" colspan="1">&#x02003;15-49&#x02009;years</td><td rowspan="1" colspan="1">5,578,619</td><td rowspan="1" colspan="1">141.28 (127.88-158.35)</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">34% of people who have experienced an intracerebral hemorrhage and are currently living are people aged between 15 and 49&#x02009;years</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x0003c;70&#x02009;years</td><td rowspan="1" colspan="1">13,567,587</td><td rowspan="1" colspan="1">183.42 (167.18-201.27)</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">82% of people who have experienced an intracerebral hemorrhage and are currently living are aged less than 70&#x02009;years</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Men (all ages)</td><td rowspan="1" colspan="1">9,349,225</td><td rowspan="1" colspan="1">236.13 (214.55-258.66)</td><td rowspan="1" colspan="1">225.08 (204.86-245.59)</td><td rowspan="1" colspan="1">56% of people who have experienced an intracerebral hemorrhage and are currently living are men</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Women (all ages)</td><td rowspan="1" colspan="1">7,254,612</td><td rowspan="1" colspan="1">184.50 (169.32-201.55)</td><td rowspan="1" colspan="1">166.10 (152.2-181.16)</td><td rowspan="1" colspan="1">44% of people who have experienced an intracerebral hemorrhage and are currently living are women</td></tr><tr><td colspan="5" rowspan="1">Deaths</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Ages (all), sexes (both)</td><td rowspan="1" colspan="1">3,308,367</td><td rowspan="1" colspan="1">41.92 (38.28-45.55)</td><td rowspan="1" colspan="1">39.09 (35.65-42.45)</td><td rowspan="1" colspan="1">Over three million people die from intracerebral hemorrhage annually</td></tr><tr><td rowspan="1" colspan="1">&#x02003;15-49&#x02009;years</td><td rowspan="1" colspan="1">263,710</td><td rowspan="1" colspan="1">6.68 (6.09-7.35)</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">About 8% of all deaths from intracerebral hemorrhage occur in people 15&#x02013;49&#x02009;years old</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x0003c;70&#x02009;years</td><td rowspan="1" colspan="1">1,524,337</td><td rowspan="1" colspan="1">20.61 (18.86-22.33)</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">46% of deaths from intracerebral hemorrhage occur in people under 70&#x02009;years old</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Men (all ages)</td><td rowspan="1" colspan="1">1,822,740</td><td rowspan="1" colspan="1">46.04 (41.18-51.72)</td><td rowspan="1" colspan="1">47.43 (42.33-53.18)</td><td rowspan="1" colspan="1">55% of all deaths from intracerebral hemorrhage are in men</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Women (all ages)</td><td rowspan="1" colspan="1">1,485,627</td><td rowspan="1" colspan="1">37.78 (33.33-42.41)</td><td rowspan="1" colspan="1">32.09 (28.31-35.99)</td><td rowspan="1" colspan="1">45% of all deaths from intracerebral hemorrhage are in women</td></tr><tr><td colspan="5" rowspan="1">DALYs</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Ages (all), sexes (both)</td><td rowspan="1" colspan="1">79,457,427</td><td rowspan="1" colspan="1">1,006.89 (921.88-1083.21)</td><td rowspan="1" colspan="1">923.64 (844.83-993.18)</td><td rowspan="1" colspan="1">Almost 79 million years of healthy life is lost each year due to intracerebral hemorrhage-related death and disability</td></tr><tr><td rowspan="1" colspan="1">&#x02003;15-49&#x02009;years</td><td rowspan="1" colspan="1">13,794,941</td><td rowspan="1" colspan="1">349.36 (318.36-381.99)</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">17% of healthy life lost due to intracerebral hemorrhage-related death and disability affects people between that age of 15 and 49&#x02009;years old</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x0003c;70&#x02009;years</td><td rowspan="1" colspan="1">52,995,320</td><td rowspan="1" colspan="1">716.44 (659.73-775.55)</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">67% of healthy life lost due to intracerebral hemorrhage-related death and disability affects people under the age of 70&#x02009;years</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Men (all ages)</td><td rowspan="1" colspan="1">45,786,602</td><td rowspan="1" colspan="1">1156.41 (1042.85-1290.26)</td><td rowspan="1" colspan="1">1123.09 (1014.11-1251.66)</td><td rowspan="1" colspan="1">Men account for 58% of healthy life lost due to intracerebral hemorrhage-related disability</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Women (all ages)</td><td rowspan="1" colspan="1">33,670,825</td><td rowspan="1" colspan="1">856.34 (759-950.46)</td><td rowspan="1" colspan="1">742.51 (657.65-822.69)</td><td rowspan="1" colspan="1">Women account for 42% of healthy life lost due to intracerebral hemorrhage-related disability</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="table-fn1-17474930241307876"><label>a</label><p>95% uncertainty interval (UI) represents a range of values that reflects the certainty of an estimate. In GBD, every estimate is calculated 1000 times, each time sampling from distributions rather than point estimates for data inputs, data transformations, and model choice.</p></fn></table-wrap-foot></table-wrap><fig position="float" id="fig3-17474930241307876"><label>Figure 3.</label><caption><p>Percentage of all DALYs caused by intracerebral hemorrhage, attributable to specific risk factors. The top 10 risk factors are shown with 95% uncertainty interval. Data from Global Burden of Disease study, all ages, both sexes, globally, in 2021.</p></caption><graphic xlink:href="10.1177_17474930241307876-fig3" position="float"/></fig><p>The vision of the World Stroke Organization (WSO) is for a world where people live free from the effects of stroke. This vision drives a global effort to improve stroke prevention, treatment, rehabilitation, and support.<sup>
<xref rid="bibr7-17474930241307876" ref-type="bibr">7</xref>
</sup> The WSO advocates with governments, system leaders, healthcare providers, and the general public, to drive improvements in public health to reducing the risk of stroke, and for the ready availability of acute stroke treatments and rehabilitation for those affected by stroke. Accurate, up-to-date information on the burden of stroke and its subtypes underpin these efforts. ICH has different but overlapping risk factors to ischemic stroke and increasing different treatments, thus it remains important to consider it both as part of the clinical syndrome of stroke and as a separate disease entity.</p></sec><sec id="section7-17474930241307876"><title>Methods</title><p>Data in this factsheet have been obtained from the Global Burden of Disease Collaborative Network, Global Burden of Disease Study 2021 Results, Seattle, United States: Institute for Health Metrics and Evaluation (IHME). Data are available from <ext-link xlink:href="https://vizhub.healthdata.org/gbd-results/" ext-link-type="uri">https://vizhub.healthdata.org/gbd-results/</ext-link>. Data were downloaded from the GBD results platform using &#x0201c;intracerebral hemorrhage&#x0201d; as a Level 4 cause of death or injury, extracting key metrics (number, percent, rate) for measures (incidence, DALYs, deaths) described in this factsheet. DALYs by country were extracted for <xref rid="fig2-17474930241307876" ref-type="fig">Figure 2</xref>. Estimates for risk factors up to level 4 were also extracted for intracerebral hemorrhage. All data are age-standardized, unless stated otherwise.</p></sec><sec id="section8-17474930241307876"><title>Discussion</title><p>This WSO Global ICH Fact Sheet 2025 and accompanying infographic (<xref rid="fig4-17474930241307876" ref-type="fig">Figure 4</xref>) provide the most updated information that can be used to inform communication with all internal and external stakeholders, inform healthcare policy, and raise public awareness; all statistics have been reviewed and approved for use by the WSO Executive Committee. The facts are endorsed by the WSO and will be updated every 1&#x02013;2&#x02009;years as new data emerges.</p><fig position="float" id="fig4-17474930241307876"><label>Figure 4.</label><caption><p>Infographic.</p></caption><graphic xlink:href="10.1177_17474930241307876-fig4" position="float"/></fig></sec></body><back><fn-group><fn fn-type="con"><p><bold>Author contributions:</bold> A.R.P.-J. accessed Global Burden of Disease Data, prepared the figures, and created the first draft of the manuscript. All authors critically reviewed and edited the manuscript and approved the final version for publication.</p></fn><fn fn-type="COI-statement"><p>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding:</bold> The author(s) received no financial support for the research, authorship, and/or publication of this article.</p></fn><fn fn-type="other"><p><bold>Ethical considerations:</bold> No specific ethical approval was required for this manuscript.</p></fn><fn fn-type="other"><p><bold>ORCID iDs:</bold> Adrian R Parry-Jones <inline-graphic xlink:href="10.1177_17474930241307876-img1.jpg"/>
<ext-link xlink:href="https://orcid.org/0000-0002-4462-3846" ext-link-type="uri">https://orcid.org/0000-0002-4462-3846</ext-link></p><p>Ashkan Shoamanesh <inline-graphic xlink:href="10.1177_17474930241307876-img1.jpg"/>
<ext-link xlink:href="https://orcid.org/0000-0002-2802-1626" ext-link-type="uri">https://orcid.org/0000-0002-2802-1626</ext-link></p><p>Simiao Wu <inline-graphic xlink:href="10.1177_17474930241307876-img1.jpg"/>
<ext-link xlink:href="https://orcid.org/0000-0002-4557-7386" ext-link-type="uri">https://orcid.org/0000-0002-4557-7386</ext-link></p></fn></fn-group><ref-list><title>References</title><ref id="bibr1-17474930241307876"><label>1</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Feigin</surname><given-names>VL</given-names></name>
<name><surname>Branin</surname><given-names>M</given-names></name>
<name><surname>Norving</surname><given-names>B</given-names></name>
</person-group>, <etal>et al</etal>. <article-title>World Stroke Organization (WSO): global stroke fact sheet 2022</article-title>. <source>Int J Stroke</source>
<year>2022</year>; <volume>17</volume>: <fpage>18</fpage>&#x02013;<lpage>29</lpage>.<pub-id pub-id-type="pmid">34986727</pub-id>
</mixed-citation></ref><ref id="bibr2-17474930241307876"><label>2</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Naghavi</surname><given-names>M</given-names></name>
<name><surname>Ong</surname><given-names>KL</given-names></name>
<name><surname>Aali</surname><given-names>A</given-names></name>
</person-group>, <etal>et al</etal>. <article-title>Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990&#x02013;2021: a systematic analysis for the Global Burden of Disease Study 2021</article-title>. <source>Lancet</source>
<year>2024</year>; <volume>403</volume>: <fpage>2100</fpage>&#x02013;<lpage>2132</lpage>.<pub-id pub-id-type="pmid">38582094</pub-id>
</mixed-citation></ref><ref id="bibr3-17474930241307876"><label>3</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Puy</surname><given-names>L</given-names></name>
<name><surname>Parry-Jones</surname><given-names>AR</given-names></name>
<name><surname>Sandset</surname><given-names>EC</given-names></name>
<name><surname>Dowlatshahi</surname><given-names>D</given-names></name>
<name><surname>Ziai</surname><given-names>W</given-names></name>
<name><surname>Cordonnier</surname><given-names>C.</given-names></name>
</person-group>
<article-title>Intracerebral haemorrhage</article-title>. <source>Nat Rev Dis Primers</source>
<year>2023</year>; <volume>9</volume>: <fpage>14</fpage>.<pub-id pub-id-type="pmid">36928219</pub-id>
</mixed-citation></ref><ref id="bibr4-17474930241307876"><label>4</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Greenberg</surname><given-names>SM</given-names></name>
<name><surname>Ziai</surname><given-names>WC</given-names></name>
<name><surname>Cordonnier</surname><given-names>C</given-names></name>
</person-group>, <etal>et al</etal>. <article-title>2022 guideline for the management of patients with spontaneous intracerebral hemorrhage: a guideline from the American Heart Association/American Stroke Association</article-title>. <source>Stroke</source>
<year>2022</year>; <volume>53</volume>: e282&#x02013;e361.</mixed-citation></ref><ref id="bibr5-17474930241307876"><label>5</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Parry-Jones</surname><given-names>AR</given-names></name>
<name><surname>Sammut-Powell</surname><given-names>C</given-names></name>
<name><surname>Paroutoglou</surname><given-names>K</given-names></name>
</person-group>, <etal>et al</etal>. <article-title>An intracerebral hemorrhage care bundle is associated with lower case fatality</article-title>. <source>Ann Neurol</source>
<year>2019</year>; <volume>86</volume>: <fpage>495</fpage>&#x02013;<lpage>503</lpage>.<pub-id pub-id-type="pmid">31291031</pub-id>
</mixed-citation></ref><ref id="bibr6-17474930241307876"><label>6</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ma</surname><given-names>L</given-names></name>
<name><surname>Hu</surname><given-names>X</given-names></name>
<name><surname>Song</surname><given-names>L</given-names></name>
</person-group>, <etal>et al</etal>. <article-title>The third Intensive Care Bundle with Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT3): an international, stepped wedge cluster randomised controlled trial</article-title>. <source>Lancet</source>
<year>2023</year>; <volume>402</volume>: <fpage>27</fpage>&#x02013;<lpage>40</lpage>.<pub-id pub-id-type="pmid">37245517</pub-id>
</mixed-citation></ref><ref id="bibr7-17474930241307876"><label>7</label><mixed-citation publication-type="webpage">
<collab>World Stroke Organization (WSO)</collab>. <ext-link xlink:href="https://www.world-stroke.org/" ext-link-type="uri">https://www.world-stroke.org/</ext-link> (<comment>accessed 18 September 2024</comment>).</mixed-citation></ref></ref-list></back></article>